Defeating the ministers.., p.28

Defeating the Ministers of Death, page 28

 

Defeating the Ministers of Death
Select Voice:
Brian (uk)
Emma (uk)  
Amy (uk)
Eric (us)
Ivy (us)
Joey (us)
Salli (us)  
Justin (us)
Jennifer (us)  
Kimberly (us)  
Kendra (us)
Russell (au)
Nicole (au)



Larger Font   Reset Font Size   Smaller Font  

  John Walker-Smith: Walker-Smith v General Medical Council. [2012] EWHC 503 (Admin) Case No: CO/7039/2010; Dyer C. Co-author of Wakefield paper on MMR vaccine wins his appeal against decision by GMC to strike him off. BMJ 20122; 344: e1745, www.bmj.com/content/344/bmj.e1745.

  Measles mmunisation rates: Measles notifications and deaths in England and Wales: 1940 to 2016. Public Health England. www.gov.uk/government/publications/measles-deaths-by-age-group-from-1980-to-2013-ons-data/measles-notifications-and-deaths-in-england-and-wales-1940-to-2013; McBrien J et al. Measles outbreak in Dublin, 2000. Pediatr Infect Dis J 2003; 22: 580–4; Zelinski A. Number of unvaccinated children has soared. Houston Chronicle, 13 April 2017, www.houstonchronicle.com/news/local/article/number-of-un-vaccinated-children-has-soared-11071051.php.

  Rotavirus: Soares-Weiser K et al. Vaccines for preventing rotavirus diarrhoea: vaccines in use. Cochrane Database Syst Rev 2012: 11; CD008521; Australian Government Department of Health. The Australian Immunisation Handbook. 10th ed. Canberra: Commonwealth of Australia, 2015, 4.17.11, Rotavirus, Adverse effects, www.immunise.health.gov.au/internet/immunise/publishing.nsf/Content/Handbook10-home~handbook10part4~handbook10–4-17#4.17.11; Kassim P, Eslick GD. Risk of intussusception following rotavirus vaccination: an evidence based meta-analysis of cohort and case-control studies. Vaccine 2017; 35: 4276–86.

  OPV versus IPV: Tucker AW et al. Cost-effectiveness analysis of changing from live oral poliovirus vaccine to inactivated poliovirus vaccine in Australia. Aust NZ J Public Health 2001; 25:411–6.

  CHAPTER 12: The modern anti-immunisation movement

  Jenny McCarthy: Offit P. Autism’s False Prophets: Bad Medicine, Risky Medicine, and the Search for a Cure. Columbia: Columbia University Press, 2008.

  MMR immunisation in the United States: National Center for Health Statistics: immunization. Centers for Disease Control and Prevention, www.cdc.gov/nchs/fastats/immunize.htm.

  Andrew Wakefield in the United States: Whipple, T. Who is Andrew Wakefield and what’s his link to Donald Trump? The Times, 8 May 2017.

  Donald Trump: Trump DJ. Tweet, 28 March 2014, twitter.com/realdonaldtrump/status/449525268529815552?lang=en; Freedman A. Trump decries ‘tremendous increase’ in US autism cases. But it’s not so simple. Mashable, 15 February 2017, www.yahoo.com/news/trump-decries-tremendous-increase-u-221230113.html.

  Autism: Kanner L. Autistic disturbances of affective contact. Nervous Child 1943; 2: 217–250.

  George Bernard Shaw: Shaw GB. The Doctor’s Dilemma, Getting Married, and the Shewing-Up of Blanco Posnet. New York: Brentano’s, 1911.

  Julie Leask: Attwell K, Leask J et al. Vaccine rejecting parents’ engagement with expert systems that inform vaccination programs. Bioethical Enquiry 2017; 14: 65, link.springer.com/article/10.1007/s11673– 016–9756–7; Leask J et al. Should we do battle with antivaccination activists? Public Health Res Pract 2015; 25: e2521515, www.phrp.com.au/issues/march-2015-volume-25-issue-2/should-we-do-battle-with-antivaccination-activists; Dunn AG, Surian D, Leask J et al. Mapping information exposure on social media to explain differences in HPV vaccine coverage in the United States. Vaccine 2017; 35: 3033–40, www.sciencedirect.com/science/article/pii/S0264410X17305522.

  Pru Hobson-West: Hobson-West P. ‘Trusting blindly can be the biggest risk of all’: organised resistance to childhood vaccination in the United Kingdom. Sociol Health Illn 2007; 29: 198–215, dx.doi.org/10.1111/j.1467–9566.2007.00544.x.

  Vaccines and immune system stimulation: Higgins JPT et al. Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review. BMJ 2016; 355: i5170, www.bmj.com/content/355/bmj.i5170.long; Kandasamy R et al. Non-specific immunological effects of selected routine childhood immunisations: systematic review. BMJ 2016; 355: i5225, www.bmj.com/content/355/bmj.i5225

  HPV immunisation in Japan: Hanley SJ et al. HPV vaccination crisis in Japan. Lancet 2015; 385: 2571.

  HPV immunisation in France: Lefèvre H et al. HPV vaccination rate in French adolescent girls: an example of vaccine distrust. Arch Dis Child 2018; 103: 740–6, adc.bmj.com/content/103/8/740.

  HPV immunisation in the United States: Udesky L. Push to mandate HPV vaccine triggers backlash in USA. Lancet 2007; 369: 979–80; Knox R. HPV vaccine: the science behind the controversy. NPR, 19 September 2011, www.npr.org/2011/09/19/140543977/hpv-vaccine-the-science-behind-the-controversy; national Center for Health Statistics: immunization. Centers for Disease Control and Prevention, www.cdc.gov/nchs/fastats/immunize.htm.

  HPV immunisation in Australia: Coverage data. National HPV Vaccination Program Register, www.hpvregister.org.au/research/coverage-data.

  Katie Couric: Jaslow R. Katie Couric admits disproportionate reporting on HPV vaccine controversy. CBS News, 10 December 2013, www.cbsnews.com/news/katie-couric-hpv-vaccine-show-criticism-valid/; Couric K. Furthering the conversation on the HPV vaccine. Huffpost, 10 December 2013, www.huffingtonpost.com/katie-couric/vaccine-hpv-furthering-conversation_b_4418568.html?1386687305.

  Merck: Tomljenovic L, Shaw CA. Too fast or not too fast: the FDA’s approval of Merck’s HPV vaccine Gardasil. J Law Med Ethics 2012; 40: 673–81.

  Trust: Birkhäue J et al. Trust in the healthcare professional and health outcome: a meta-analysis. PLoS One 2017; 12: e0170988, www.ncbi.nlm.nih.gov/pmc/articles/PMC5295692/pdf/pone.0170988.pdf.

  Hepatitis B immunisation in France: Ascherio A et al. Hepatitis B vaccination and the risk of multiple sclerosis. N Engl J Med 2001; 344: 327–32; Le Houézec D. Evolution of multiple sclerosis in France since the beginning of hepatitis B vaccination. Immunol Res. 2014; 60: 219-25, www.ncbi.nlm.nih.gov/pmc/articles/PMC4266455/.

  CHAPTER 13: Immunisation and ethics

  Hippocrates: Lloyd GER (ed), Chadwick J (transl). Hippocratic Writings. London: Penguin Classics, 1950.

  Bioethics: Kerridge I, Lowe M, Stewart C. Ethics, Law and the Health Profession. 4th ed. Sydney: Federation Press, 2013.

  Nazi doctors: Annas GJ, Grodin MA (eds). The Nazi Doctors and the Nuremberg Code. New York: Oxford University Press, 1992.

  Tuskegee Study: Jones JH. Bad Blood: The Tuskegee Syphilis Experiment. New York: The Free Press, 1993; US Public Health Service syphilis study at Tuskegee: presidential apology. Centers for Disease Control and Prevention, 16 May 1997, www.cdc.gov/tuskegee/clintonp.htm.

  Willowbrook experiments: Fansiwala K. The duality of medicine: the Willowbrook State School experiments. The Review & Debates, 20 February 2016, www.thereviewatnyu.com/all/2016/2/20/the-duality-of-medicine-the-willowbrook-state-school-experiments.

  Vaccines developed from aborted foetuses: Luño AR. Ethical reflections on vaccines using cells from aborted foetuses. National Catholic Bioethics Quarterly 2006; 6: 453–9, www.ncbcenter.org/index.php/download_file/force/178/159/; Vatican statement on vaccines derived from aborted human foetuses. Immunization Action Coalition, www.immunize.org/concerns/vaticandocument.htm.

  Tom Beauchamp and Jim Childress: Beauchamp TL, Childress JF. Principles of Biomedical Ethics. New York: Oxford University Press, 1977.

  John Stuart Mill: Mill JS. On Liberty. London: John W Parker & Son, 1859, ebooks.adelaide.edu.au/m/mill/john_stuart/m645o/index.html.

  Hepatitis B intervention: Isaacs D. Children have rights, too. J Paediatr Child Health 2009; 45: 627–8, onlinelibrary.wiley.com/doi/10.1111/j.1440–1754.2009.01620.x/full; Isaacs D et al. Ethical issues in preventing mother-to-child transmission of hepatitis B by immunisation. Vaccine 2011; 29: 6159–62.

  Rabies interventions: Hampson K et al. Rabies exposures, post-exposure prophylaxis and deaths in a region of endemic canine rabies. PLoS Negl Trop Dis 2008; 2: e339, www.ncbi.nlm.nih.gov/pmc/articles/PMC2582685/.

  2017 European measles outbreaks: Measles continues to spread and take lives in Europe. World Health Organization, Regional Office for Europe, 11 July 2017, www.euro.who.int/en/media-centre/sections/press-releases/2017/measles-continues-to-spread-and-take-lives-in-europe; Measles outbreaks still ongoing in 2018 and fatalities reported from four countries. European Centre for Disease Prevention and Control, 9 March 2018, ecdc.europa.eu/en/news-events/measles-outbreaks-still-ongoing-2018-and-fatalities-reported-four-countries.

  Belgium polio case: Stafford N. Belgian parents are sentenced to prison for not vaccinating children. BMJ 2008; 336: 348, www.bmj.com/content/336/7640/348.1.full.

  No Jab No Play/Pay: No Jab No Play, No Jab No Pay policies. National Centre for Immunisation Research & Surveillance, www.ncirs.edu.au/consumer-resources/no-jab-no-play-no-jab-no-pay-policies/.

  Northern New South Wales tetanus case: MacKenzie B. Vaccination debate flares on NSW north coast after 7yo contracts tetanus. ABC News, 16 March 2017,www.abc.net.au/news/2017–03–17/tetanus-girl-not-vaccinated-say-health-authorities/8362722.

  Indiana hospital case: Lupkin S. Eight hospital employees fired for refusing flu vaccines. ABC News (United States), 3 January 2012, abcnews.go.com/Health/indiana-hospital-fires-nurses-refusing-flu-shot/story?id=18116967.

  Vaccine injury compensation schemes: National Vaccine Injury Compensation Program. Health Resources & Services Administration, www.hrsa.gov/vaccine-compensation/index.html; Looker C, Kelly H. No-fault compensation following adverse events attributed to vaccination: a review of international programmes. Bull WHO 2011; 89: 371–8, www.ncbi.nlm.nih.gov/pmc/articles/PMC3089384/; Isaacs D. Should Australia introduce a vaccine injury compensation scheme? J Paediatr Child Health 2004; 40: 247–9.

  CHAPTER 14: Overcoming the iniquity of poverty

  Immunisation statistics: Immunization. World Health Organization, www.who.int/topics/immunization/en/.

  WHO Expanded Programme on Immunization: The immunization programme that saved millions of lives. Bull WHO 2014; 92: 314–5, www.who.int/bulletin/volumes/92/5/14–020514/en/.

  Halfdan Mahler: De Leeuw E. A tribute to Dr Halfdan Mahler, 1923– 2016. Health Prom Int 2017; 32: 1, academic.oup.com/heapro/article/32/1/1/2964736.

  UNICEF: Adamson P et al. Jim Grant: UNICEF Visionary. Geneva: UNICEF Innocenti Research Centre, 2001, www.unicef.org/french/publications/files/Jim-Grant-LR.pdf; United Nations Children’s Fund, World Health Organization. Immunization Summary: A Statistical Reference Containing Data Through 2011. New York: United Nations Children’s Fund, 2012, www.unicef.org/immunization/files/En-ImmSumm-2013.pdf;UNICEF people: Danny Kaye. UNICEF, www.unicef.org/people/people_danny_kaye.html.

  March of Dimes: Rose D. A history of the March of Dimes, March of Dimes, 26 August 2010, www.marchofdimes.org/mission/a-history-of-the-march-of-dimes.aspx.

  Rotary: Our foundation. Rotary, www.rotary.org/en/about-rotary/rotary-foundation; You’ve probably never heard of Clem Renouf – but his idea changed the world. I Boost Immunity, iboostimmunity.com/articles/youve-probably-never-heard-clem-renouf-his-idea-changed-world; End polio. Rotary, my.rotary.org/en/take-action/end-polio.

  Bill and Melinda Gates: Bill & Melinda Gates Foundation, www.gatesfoundation.org/; Gavi, the Vaccine Alliance, www.gavi.org/.

  HPV immunisation: Millions of girls in developing countries to be protected against cervical cancer thanks to new HPV vaccine deals. Gavi, The Vaccine Alliance, 9 May 2013, www.gavi.org/library/news/press-releases/2013/hpv-price-announcement/; Gallagher KE et al. Status of HPV vaccine introduction and barriers to country uptake. Vaccine 2018; 36: 4761–7, www.sciencedirect.com/science/article/pii/S0264410X18301671?via%3Dihub.

  Hepatitis B immunisation: Hepatitis B, World Health Organization, www.who.int/immunization/diseases/hepatitisB/en/.

  Measles immunisation: Measles, World Health Organization, www.who.int/immunization/diseases/measles/en/.

  Cameron government: Heppell T, Lightfoot S. ‘We will not balance the books on the backs of the poorest people in the world’: understanding Conservative Party strategy on international aid. Political Q 2012; 83: 130–8; Cameron D. David Cameron: why we’re right to ringfence the aid budget. Guardian, 12 June 2011,www.theguardian.com/global-development/2011/jun/11/david-cameron-defends-aid-funding.

  Paul Wilson report: Wilson P. Giving Developing Countries the Best Shot: An Overview of Vaccine Access and R&D. Oxfam International, Médecins Sans Frontières, 2010, www.oxfam.org/sites/www.oxfam.org/files/giving-developing-countries-best-shot-vaccines-2010–05.pdf.

  Meningococcal C vaccine: Trotter CL et al. Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction. Lancet 2004; 364: 365–7, www.thelancet.com/journals/lancet/article/PIIS0140–6736(04)16725–1/fulltext.

  PATH: Better health moves humanity forward. PATH, www.path.org/about/index.php.

  Meningitis Vaccine Project: Kiffay T et al. The evolution of the Meningitis Vaccine Project. Clin Infect Dis 2015; 61 (Suppl 5): S396–403, www.ncbi.nlm.nih.gov/pmc/articles/PMC4639496/.

  Meningococcal A immunisation in Chad: Daugla DM et al. Effect of a serogroup A meningococcal conjugate vaccine (PsA–TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study. Lancet 2014; 383: 40–7, www.thelancet.com/journals/lancet/article/PIIS0140–6736(13)61612–8/fulltext.

  Immunisation coverage: Immunization coverage. World Health Organisation, www.who.int/mediacentre/factsheets/fs378/en/.

  CHAPTER 15: Immunisation into the future

  Top 10 causes of death: The top 10 causes of death. World Health Organization, www.who.int/en/news-room/fact-sheets/detail/the-top-10-causes-of-death.

  Effective use of vaccines: Investing in Immunisation Through the GAVI Alliance: The Evidence Base, Geneva: GAVI Alliance, 2012, www.gavi.org/library/publications/the-evidence-base/investing-in-immunisation-through-the-gavi-alliance---the-evidence-base/.

  Malaria: Gomes PS et al. Immune escape strategies of malaria parasites. Front Microbiol 2016; 7: 1617,www.ncbi.nlm.nih.gov/pmc/articles/PMC5066453/.

  HIV: Naughtie A. HIV ‘invisibility cloak’ allows virus to evade immune system. The Conversation, 7 November 2013, theconversation.com/hiv-invisibility-cloak-allows-virus-to-evade-immune-system-19918; Understanding how HIV evades the immune system. Science Daily, 21 February 2017, www.sciencedaily.com/releases/2017/02/170221110654.htm.

  Malaria statistics: Malaria. World Health Organization, www.who.int/malaria/en/.

  HIV statistics: HIV. World Health Organization, www.who.int/hiv/en/.

  Dementia statistics: Dementia: A Public Health Priority. Geneva: World Health Organization, Alzheimer’s Disease International, 2012, www.who.int/mental_health/neurology/dementia/en/.

  Dementia vaccines: Marciani DJ. A retrospective analysis of the Alzheimer’s disease vaccine progress – the critical need for new development strategies. J Neurochem 2016; 137: 687–700, onlinelibrary.wiley.com/doi/10.1111/jnc.13608/epdf; Pasquier F et al. Two phase 2 multiple ascending-dose studies of vanutide cridificar (ACC-001) and QS-21 adjuvant in mild-to-moderate Alzheimer’s disease. J Alzheimers Dis 2016; 51: 1131–43, content.iospress.com/articles/journal-of-alzheimers-disease/jad150376; novak P et al. Safety and immunogenicity of the tau vaccine AADvac1 in patients with Alzheimer’s disease: a randomised, double-blind, placebo-controlled, phase 1 trial. Lancet Neurol 2017; 16: 123–34, www.sciencedirect.com/science/article/pii/S1474442216303313?via%3Dihub.

  Helicobacter pylori: Ming Z et al. Efficacy, safety, and immunogenicity of an oral recombinant Helicobacter pylori vaccine in children in China: a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 2015; 386: 1457–64, www.thelancet.com/pdfs/journals/lancet/PIIS0140–6736(15)60310–5.pdf; Muljono DH. In conversation with Barry Marshall: using pathogens to help humans. The Conversation, 30 March 2016, theconversation.com/in-conversation-with-barry-marshall-using-pathogens-to-help-humans-56153.

  Edible vaccines: Concha C et al. Disease prevention: an opportunity to expand edible plant-based vaccines? Vaccines (Basel) 2017; 5: 14, ncbi.nlm.nih.gov/pmc/articles/PMC5492011/.

  Nasal RSV vaccine: Neuzil KM. Progress toward a respiratory syncytial virus vaccine. Clin Vaccine Immunol 2016; 23: 186–8, cvi.asm.org/content/23/3/186.full.

  Jet injectors: Resik S et al. Needle-free jet injector intradermal delivery of fractional dose inactivated poliovirus vaccine: association between injection quality and immunogenicity. Vaccine 2015; 33: 5873–7, www.sciencedirect.com/science/article/pii/S0264410X15008725?via%3Dihub; Jackson L et al. Safety and immunogenicity of varying dosages of trivalent inactivated influenza vaccine administered by needle-free jet injectors. Vaccine 2001; 19: 4703–9, www.sciencedirect.com/science/article/pii/S0264410X01002250?via%3Dihub; Canter J et al. An outbreak of hepatitis B associated with jet injections in a weight reduction clinic. Arch Internal Med 1990; 150: 1923–7, jamanetwork.com/journals/jamainternalmedicine/article-abstract/613868.

  Microneedles: Pearson FE et al. Functional anti-polysaccharide IgG titres induced by unadjuvanted pneumococcal-conjugate vaccine when delivered by microprojection-based skin patch. Vaccine 2015; 33: 6675–83, www.sciencedirect.com/science/article/pii/S0264410X15015248?via%3Dihub; Van der Maaden K et al. Microneedle technologies for (trans)dermal drug and vaccine delivery. J Control Release 2012; 161: 645–55, www.sciencedirect.com/science/article/pii/S0168365912000740?via%3Dihub; Raphael AP et al. Formulations for microprojection/microneedle vaccine delivery: structure, strength and release profiles J Control Release 2016; 225: 40–52, www.sciencedirect.com/science/article/pii/S0168365916300220?via%3Dihub; Rouphael nG et al. The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled, phase 1 trial. Lancet 2017; 390: 649–58, www.thelancet.com/journals/lancet/article/PIIS0140-6736(17)30575-5/fulltext.

 

Add Fast Bookmark
Load Fast Bookmark
Turn Navi On
Turn Navi On
Turn Navi On
Scroll Up
Turn Navi On
Scroll
Turn Navi On
183